Receptors for C3 bind ligand and generate intracellular signals that lead to the engulfment of C3-coated particles. Recent experiments suggest that both the binding and the subsequent signal transduction activities of C3 receptors can be regulated. Cultured human monocytes (MO) 1 express receptors for C3b (CR1) and C3bi (CR3) that bind ligand-coated particles but do not signal the cell to initiate phagocytosis. After stimulation of the MO with PMA (1), or after interaction of the MO with surfaces coated with fibronectin (Fn, reference 2), CR1 and CR3 readily generate signals leading to phagocytosis. Thus PMA and Fn regulate the signaling capacity of CR1 and CR3 in these cells. In polymorphonuclear leukocytes, both the binding and the signaling activities are coordinately regulated. Brief (15 min) stimulation with PMA increases binding and signaling activities of CR 1 and CR3, but prolonged (60 min) incubation with PMA eliminates both binding and signaling (3). Since the PMA-mediated decline in the binding capacity of CR1 and CR3 is not accompanied by a loss of cell surface receptors, it appears that PMA regulates the binding and signaling activities of existing cell surface receptors.
prepared as follows. Cells were suspended at 0.75 × 10~/ml in PBS (137 mM NaCl; 2.7 mM KCI; 0.9 mM CaCI2; 0.5 mM MgCI2; 8 mM phosphate, pH 7.4) containing 3 mM glucose, 0.5 mg/ml human serum albumin (HSA [Worthington Biochemical Corp., Freehold, NJ]), and 0.3 U/ml aprotinin. Terasaki tissue culture plates (Miles Laboratories Inc., Naperville, IL) were coated with HSA (1 mg/ml), Fn (100 ~g/ml, Greater New York Blood Center), or OKM10 (50 ~g/ml) by a 60 min incubation at 20°C. The culture surfaces were washed, 5 ul MO suspension was added per well, and cells were allowed to spread at 37°C for 45 rain.
Attachment of ligand-coated E to monolayers of MO was determined by adding 5 × 105 E/well and incubating for 45 min at 37°C. The attachment of E to MO was scored by phase contrast microscopy as previously described (1) . Measurement of phagocytosis was made in a similar fashion and was scored after lysing uningested E by a brief exposure to distilled water. Results are reported as attachment index or phagocytic index, i.e., the number of E bound or phagocytosed per 100 phagocytes.
Expression of Receptor Protein on the Cell Surface.
Monolayers of adherent MO prepared as described above were immersed in cold PBS without divalent cations (PD) containing 1% FCS (PDFCS). Saturating amounts of mAbs (5 #g/ml) were then added to duplicate wells and the plates were incubated at 0°C for 50 rain. The monolayers were thoroughly washed and incubated with 5/~g/ml J25I-F(ab)2 anti-IgG for an additional 50 min at 0°C. After washing, individual wells were cut from the Terasaki plate and cell-bound radioactivity was counted in a gamma counter. Background binding was measured in wells without primary antibody. Background binding varied from 75-150 cpm/well, and the binding to cells ranged from 1,500 cpm/well (3D9) to 20,000 cpm/well (OKM 10). Control experiments showed that MO remained attached to the culture wells throughout the incubations.
Electron Microscopy. Control of IFN-~,-treated MO were plated on plastic surfaces coated with HSA or OKM10 for 60 min at 37°C. The location of CR3 was then determined by methods to be described in detail elsewhere (Detmers, P. A., et al., manuscript in preparation). In brief, the cells were fixed in 0.2% glutaraldehyde, 1% ethyldimethylaminopropyl carbodiimide (11), quenched with 0.5 mg/ml NaBH4 in PBS, and incubated sequentially with PDFCS, biotinylated OKM 10 (5 #g/ml in PD containing 1 mg/ml HSA), and streptavidin-conjugated, 5-nm colloidal gold, with washes after the last two incubations. Labeled cells were fixed in glutaraldehyde and osmium tetroxide (12) , dehydrated in a graded series of ethanol, and removed from the plastic surfaces by addition of propylene oxide (13) . Monolayers pelleted by centrifugation in a microcentrifuge were embedded in Epon, sectioned, stained with uranyl acetate and lead citrate, and viewed at 80 kV on a 100CX microscope (JEOL USA, Peabody, MA). Control preparations included: (a) omission of biotinylated OKM10 and (b) addition of a 70-fold excess on nonbiotinylated OKM 10 with the biotinylated OKM 10. No labeling with streptavidin gold was observed in either of these two cases (data not shown).
Results

IFN-,y Decreases the Capacity of MO To Bind
C3b and C3bi-coated Erythrocytes. IFN-'y (100 U/ml) was added at intervals to cultures of monocytes, and after 5 d the binding of EC3b and EC3bi to the MO was assessed. IFN-'y causes a sharp decline in binding of both EC3b and EC3bi, which is visible within 18 h and is maximal within 48 h (Fig. 1) . Addition of IFN-~, to MO 1 h before assay had no effect on binding (data not shown). The effect of IFN-~ does not result in a generalized depression in the capacity of MO to bind particles since the binding of EIgG is increased by treatment with IFN-"r ( Fig. 1, references 14 and 15) . A depression in the binding of EC3b and EC3bi occurs when IFN-~, is added to freshly isolated monocytes or to 5-d cultures (data not shown), suggesting that responsiveness to IFN-~ is not developmentally regulated. A single dose of IFN-~, depresses binding of EC3b and EC3bi for 48 h, but receptor activity returns to normal levels after an additional 3 d of culture (Fig. i) . We have found that MO deplete >90% of the added IFN-~ within 48 h ( Table I ), suggesting that reversal of the effects of IFN-'y may be caused by consumption of the added IFN-% This hypothesis is supported by the finding that the binding activity of CR1 and CR3 remains depressed in cultures to which fresh IFN--y was added at 48 h intervals (Fig. 1 ). These observations suggest that the effect of IFN-~ on CR1 and CR3 is reversible and requires the continued presence of IFN-% Doses of IFN-"r as low as 25 U/ml cause a sharp decline in receptor activity, and maximal depression is observed at 100 U/ml (Fig. 2) . This dose response range is comparable to that observed for IFN-'y-induced increases in Fc receptors (14) , Ia antigens (16, 17) , and peroxide-producing capacity (18) . The action of our recombinant IFN-~ preparations derives from their IFN-T content, since a neutralizing monoclonal anti-IFN-~, antibody (4) completely blocks its action (Fig.  2) . Depression of the binding activity of CR1 and CR3 is not a property shared by all interferons since IFN-a had no effect on the binding of EC3b or EC3bi to MO (data not shown).
The addition of IFN-'y to cultures of monocytes does not change the number of MO harvested after 2-5 d (data not shown), suggesting that IFN-~, does not cause either cell proliferation or cell death. The entire population of monocytes appears to respond uniformly to IFN-~, since all cells in IFN-~-treated cultures (Table I) , and thus to maintain IFN-3' levels for extended periods, fresh IFN-3" was added at 48 h intervals (O, r-l; 120 h time point). Results are representative of three separate experiments. The effect of ligand density on the binding of EC3b and EC3bi to IFN-3,-treated MO was next measured. E were prepared bearing different numbers of C3b or C3bi, and the attachment of these particles was determined using MO cultured for 5 d in the presence or absence of IFN-3, (Fig. 3) . Half-maximal binding of E to control MO was observed with about 38,000 C3b or C3bi/E. In contrast, half-maximal binding of EC3b or EC3bi to IFN-3,-treated MO could not be observed even with 120,000 C3/E. The inhibition of CR1 activity by IFN-3, appears more complete than CR3 since moderate binding of EC3bi (one third maximal) can be observed with very high levels of C3bi per E (Fig. 3) .
TABLE I
Consumption of lFN-'r by MO
IFN-'y Does Not Decrease the Number or Molecular Weight of C3 Receptors.
Though treatment of MO with IFN-3, sharply decreases the capacity of MO to bind EC3b and EC3bi, the number of C3b and C3bi receptors detected with monoclonal anti-receptor antibodies is not radically altered. IFN-q,-treated MO expressed normal levels of CR3 antigens as measured by two separate anti-CR3 antibodies (Table II) , and expression of CR1 antigen was lowered by only 25%. To observe whether all the cells in the population respond similarly to IFN-3', we measured expression of CR3 using a FACS. These studies showed a unimodal distribution of CR3 on both control and IFN-q,-treated cells (Fig. 4) . The antigens detected by our mAbs appear to be intact receptors since CR3 immunoprecipitated from 125I surface-labeled, I FN-3,-treated MO exhibited electrophoretic mobilities identical with those from untreated MO (Fig. 5) .
Effect of lFN-y on the Expression of Other Cell Surface Antigens. The expression
of several other MO antigens was measured on control and IFN-7-treated cells. LFA-1, p150,95, and CR3 are ~Jfll heterodimers composed of an a chain that is unique and a/3 chain that is common to all three proteins (19, 8) . The expression of p150,95 was unaffected by IFN-~, (Table II) , but expression of LFA-1 was increased approximately twofold (Table II and Fig. 5 ). Induction of LFA-1 by IFN-3, on murine macrophages has been recently reported (20) . We also confirmed the observations of several other investigators (16, 17) that the expression of Ia antigens is increased by IFN-y. The expression of 3C10, a marker for monocytes and macrophages (9) , is decreased approximately twofold by IFN-7.
The Ligand-binding Activity of CR1 and CR3 in IFN-y-treated MO Is Restored by
Fn. When IFN-7-treated MO were allowed to spread for 45 min on surfaces coated with Fn, the binding activity of CR1 and CR3 was fully restored (Table (Table III) . Thus, Fn enhances the capacity of CR1 and CR3 to bind ligand through an alteration in the function of existing receptors, not by a change in the number of cell-surface receptors. Interestingly, the effect of Fn on the capacity of CR1 and CR3 to mediate binding could not be mimicked with PMA (Table III) .
To test whether the effect of Fn on the binding activity of CR1 and CR3 is reversible, IFN-3,-treated MO were removed with EDTA from Fn-coated surfaces (21) and were plated on fresh HSA-or Fn-coated surfaces. IFN-~'-treated MO removed from Fn lose the ability to bind EC3b and EC3bi when they are replated for 45 min on control HSA-coated substrates (Fig. 6 ). However, binding activity can be restimulated by plating these MO on fresh Fn-coated surfaces. Thus, activation of the binding activity of CR1 and CR3 by Fn requires its continuous presence and is fully reversible.
Effect of IFN-3, on the Capacity of Receptors To Promote Phagocytosis. Previous
work had shown that treatment of MO with PMA enables CRI and CR3 to promote phagocytosis (reference 1 and Table IV ). In IFN-3,-treated MO, however, PMA stimulated neither binding (Table III) nor phagocytosis (Table IV) mediated by CR 1 or CR3. Spreading of IFN-y-treated cells on Fn-coated surfaces stimulated the capacity of CR1 and CR3 to bind ligand (Table III) , but did not enable these receptors to promote phagocytosis (Table IV) . Phagocytosis was only initiated by CR1 and CR3 when IFN-3,-treated MO were simultaneously treated with Fn and PMA (Table IV) . This observation suggests that PMA and Fn have distinct effects on CR1 and CR3; Fn enables binding and PMA enables signaling.
We have also observed that although IFN-3,-treated MO bind EIgG more avidly than untreated control cells (Figs. 1 and 2) , phagocytosis of EIgG is depressed two-to threefold in IFN-3,-treated cells (Table IV) . T h e capacity of IFN-'r-treated MO to phagocytose EIgG is partially restored by the combined action of Fn and PMA (Table IV) .
IFN-'r Does Not Alter The Mobility of CR3.
In murine macrophages, the signaling capacity of C3 receptors correlates with their mobility in the m e m b r a n e ; receptors that do not p r o m o t e phagocytosis do not diffuse to the substrateattached domain of phagocytes spread on C3-coated surfaces (22, 23) . T o observe the mobility of CR3 on IFN-3,-treated MO, cells were plated on surfaces coated with monoclonal anti-CR3 (OKM 10). Previous studies showed that the CR3 on untreated MO is redistributed by such substrates so that the apical surface of MO becomes depleted of receptors (8) . T h e distribution of CR3 on IFN-3,-treated MO could not be d e t e r m i n e d with a rosette assay because these MO do not bind EC3bi. We therefore tagged receptors with biotinylated O K M 10 and streptavidin-colloidal gold as described in Materials and Methods, and used electron microscopy to determine the cellular distribution of CR3. Fig. 7 b shows that IFN-3,-treated cells plated on HSA-coated surfaces express abundant CR3 on the apical surface. Thus, the dysfunction of CR3 in IFN-3,-treated cells is not caused by gross redistribution of receptors. Cells spread on OKM10-coated surfaces express little if any CR3 on the apical surface (Fig. 7, c and d) , indicating that the receptors diffused to the substrate-attached portion of the cell and were trapped by OKM 10. Since the extent of down-modulation of CR3 is comparable in both control and IFN-3,-treated cells, we believe that IFN-3, does not cause gross alteration of the mobility of CR3. Finally, we have observed that CR3 exists in clusters on both the control and IFN-3,-treated MO. Further studies are Monocytes were cultured for 5 d in Teflon beakers. Where indicated, 100 U/ml IFN-7 was added 48 h before the experiment. Monolayers of phagocytes were prepared and the phagocytosis of the indicated ligand-coated erythrocyte was measured as described in Materials and Methods. Data are from an experiment representative of three separate experiments. Phagocytosis was measured using monolayers of MO spread on Fn-coated surfaces. 30 ng/ml PMA was added during the incubation of MO with the ligand-coated erythrocytes. Phagocytosis was measured in the presence of 30 ng/ml PMA using MO spread on Fn-coated surfaces.
underway to determine whether the size and spacing of the clusters are influenced by IFN-3'. Discussion Here we show that cultivation of human monocytes or macrophages with recombinant IFN-'y causes a striking decrease in the capacity of CR1 and CR3 to bind particles coated with the corresponding ligand. The dysfunction of CR 1 and CR3 induced by IFN-3' appears distinct from previously described dysfunctions of receptors in macrophages, in that binding of ligand is affected. Human and mouse macrophages possess complement receptors that fail to initiate phagocytosis (1, 22) , but only IFN-7-treated MO express receptors that fail to bind ligand.
The biochemical mechanisms by which the binding activity of CR1 and CR3 are regulated by IFN-3, are not clear. Reduced binding activity is not the result of irreversible modifications such as proteolysis since the molecular weight of CR3 is not altered (Fig. 5) , and the dysfunction is rapidly reversed when the MO spread on surfaces coated with Fn (Table III) . Reduced binding activity is also not associated with decreased mobility of the cell surface receptors since they continue to diffuse readily in IFN-3,-treated MO (Fig. 7) . Finally, reduced binding activity is not associated with changes in the number of cell surface receptor molecules since the number of CR1 and CR3 is unchanged by treatment of MO with IFN-3, or with Fn (Tables II and III) . We thus propose that depression of binding activity of CR 1 and CR3 by IFN-3, is caused by reversible conformational changes in the receptors. Such conformational changes could result from posttranslational modifications such as phospborylation or methylation, or from the binding of an inhibitory subunit or an allosteric effector. Regulation of ligand binding activity has been observed for several other receptors. The binding affinity of epidermal growth factor receptors is depressed in cells treated with platelet-derived growth factor (24) , and the affinity of receptors for/3-adrenergic ligands (25) and FMLP (26) can be depressed by prior treatment of cells with ligand (homologous desensitization) or with several pharmacologic agents. Regulation of binding activity may thus represent a general mechanism for controlling a cell's responsiveness to a ligand. The observation that receptors may exist in a state incapable of binding ligand also indicates that rosette assays and other measures of ligand binding may be poor indicators of the presence or absence of receptors on a cell.
Spreading of IFN-3,-treated MO on Fn-coated surfaces enables CR1 and CR3 to bind ligand, but the receptors remain incapable of signaling phagocytosis (Tables III and IV) . Treatment of IFN-~'-treated MO with PMA enables CR1 and CR3 to generate signals for phagocytosis, but only if binding is also enabled by Fn (Table IV) . These observations suggest that the two functions of complement receptors, binding of ligand and signaling of phagocytosis, may be controlled at separate points in IFN-3,-treated cells; control of binding is exerted by Fn and control of signaling by PMA.
Our observations show that the capacity of IFN-3,-treated MO to bind C3-coated cells is under physiological regulation; binding does not occur until the cells receive an additional stimulus (Fn). Control mechanisms similar to those observed with CR1 and CR3 could potentially regulate other cell-cell adhesion events, such as the interaction of cytolytic T cells with targets, the interaction of activated macrophages with tumor cells, and the interaction of T cells with accessory cells. Since several of such cell-cell adhesion events are mediated by LFA-1, and since LFA-1 is structurally homologous to CR3 (8, 19) , we suggest that cell-cell adhesion events mediated by LFA-1 may be controlled by changes in the binding activity of LFA-1.
In contrast with the observations on complement-coated erythrocytes, the binding of EIgG is strongly enhanced in IFN-7-treated MO ( Fig. 1 and 2 ). These data are consistent with the well-documented increase in the expression of a high affinity FcR caused by IFN-'y (14, 15) . IFN-3,-treated MO, however, show decreased capacity to phagocytose EIgG (Table IV) . These data suggest that the high-affinity FcR may not efficiently promote phagocytosis. Consistent with this hypothesis are the observations that >70% of the uptake of EIgG is inhibited when the low-affinity FcR is removed from MO (27) , and clearance of IgGcoated erythrocytes is decreased 98% by antibodies against a low-affinity receptor (28) . These observations suggest that phagocytosis of IgG-coated particles by MO may be promoted primarily by a low-affinity FcR, not by the high-affinity FcR induced by IFN-% Summary Cultivation of human monocytes with recombinant IFN-7 causes a 5-10-fold depression in their binding of EC3b or EC3bi. This effect is observed within 18 h and is expressed for 5 d in the presence of 100 U/ml IFN-3'. The capacity of IFN-3,-treated phagocytes to bind EC3b and EC3bi is fully restored if the phagocytes are allowed to spread for 45 min on surfaces coated with Fn. IFN-~-treated cells express normal levels of cell surface C3b and C3bi receptors as measured with monoclonal anti-receptor antibodies, and spreading on Fn does not alter receptor number. We conclude that cultivation with IFN-~ causes a change in the nature of these receptors that prevents them from interacting with iigand. Immunoelectron microscopy shows that C3bi receptors are expressed on the apical surface of the IFN-3,-treated MO and that these receptors exhibit normal capacity to migrate in the plane of the membrane. Thus, the nature of the change caused by IFN-~/ is not related to changes in receptor number, location, or mobility. While spreading of IFN-~,-treated cells on Fn enables C3 receptors to bind ligand, it does not enable them to promote phagocytosis. Treatment of cells with PMA alone does not affect binding or phagocytosis, but treatment of cells with both Fn and PMA enables cells to phagocytose EC3b and EC3bi. These data indicate that the binding and signaling activities of C3 receptors are separately regulated. Fn enables receptors to bind ligand and PMA enables them to signal phagocytosis.
